| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5851197P | 1997-09-11 | 1997-09-11 | |
| US60058511 | 1997-09-11 | ||
| PCT/US1998/019267WO1999012576A2 (en) | 1997-09-11 | 1998-09-11 | Methods and compositions for treating cardiac and renal disorders with atrial natriuretic peptide and tissue kallikrein gene therapy |
| Publication Number | Publication Date |
|---|---|
| AU9487698Atrue AU9487698A (en) | 1999-03-29 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU94876/98AAbandonedAU9487698A (en) | 1997-09-11 | 1998-09-11 | Methods and compositions for treating cardiac and renal disorders with atrial natriuretic peptide and tissue kallikrein gene therapy |
| Country | Link |
|---|---|
| AU (1) | AU9487698A (en) |
| WO (1) | WO1999012576A2 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000071576A2 (en)* | 1999-05-24 | 2000-11-30 | Mayo Foundation For Medical Education And Research | Adenovirus vectors encoding brain natriuretic peptide |
| US6407211B1 (en)* | 1999-12-17 | 2002-06-18 | Mayo Foundation For Medical Education And Research | Chimeric natriuretic peptides |
| US7795221B2 (en) | 2006-03-30 | 2010-09-14 | Palatin Technologies, Inc. | Linear natriuretic peptide constructs |
| ES2430323T3 (en) | 2006-03-30 | 2013-11-20 | Palatin Technologies, Inc. | Cyclic natriuretic peptide constructs |
| US8580746B2 (en) | 2006-03-30 | 2013-11-12 | Palatin Technologies, Inc. | Amide linkage cyclic natriuretic peptide constructs |
| US8455438B2 (en)* | 2008-12-29 | 2013-06-04 | Mayo Foundation For Medical Education And Research | Natriuretic polypeptides for reducing or preventing restenosis |
| WO2013032784A1 (en) | 2011-08-30 | 2013-03-07 | Mayo Foundation For Medical Education And Research | Natriuretic polypeptides |
| WO2013103896A1 (en) | 2012-01-06 | 2013-07-11 | Mayo Foundation For Medical Education And Research | Treating cardiovascular or renal diseases |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5668618A (en)* | 1979-11-06 | 1981-06-09 | Green Cross Corp:The | Remedy for disease related to disorder of circulatory organ consisting essentially of kallikrein of human urine |
| Publication number | Publication date |
|---|---|
| WO1999012576A3 (en) | 1999-06-03 |
| WO1999012576A2 (en) | 1999-03-18 |
| Publication | Publication Date | Title |
|---|---|---|
| AU1520699A (en) | Methods for treatment of disorders of cardiac contractility | |
| AU4787697A (en) | Therapeutic gene | |
| AU6530600A (en) | Use of neurotoxin for treating cardiac muscle disorders | |
| AU9203998A (en) | Cardiac pacing with multiple pacing therapy features | |
| AU8659598A (en) | Iontophoretic delivery of an agent into cardiac tissue | |
| AU5963900A (en) | Muteins of bilin-binding protein | |
| AU6558098A (en) | Intracardiac defibrillation system | |
| AU3021795A (en) | Atrial defibrillator having patient activated modality | |
| AU3111700A (en) | Methods and compositions for treating inflammatory diseases utilizing inhibitorsof tumor necrosis factor activity | |
| AU2315797A (en) | Promotion of regeneration of organized tissues | |
| AU7705098A (en) | Human tumor necrosis factor receptor-like protein 8 | |
| AUPO833497A0 (en) | Improved heart pacemaker | |
| AU9487698A (en) | Methods and compositions for treating cardiac and renal disorders with atrial natriuretic peptide and tissue kallikrein gene therapy | |
| AU5020196A (en) | Human fas gene promoter region | |
| AU5262200A (en) | Arrangement in ventilatory treatment of the lungs | |
| AU2969597A (en) | Treatment of vascular lesions | |
| AU5780398A (en) | Pharmaceutical composition for treatment of heart disease based on cardiac hypertrophy | |
| AU4823999A (en) | Methods and compositions for treating diseases mediated by transglutaminase activity | |
| AU6254799A (en) | Anti-ige gene therapy | |
| AU9017598A (en) | Human frezzled-like protein | |
| AU6883398A (en) | Methods of treating bone loss | |
| AU7609298A (en) | Treatment of heart failure with growth hormone | |
| AU2171695A (en) | Agents for treating metabolic bone diseases | |
| AU6088300A (en) | Modulation of egr-1 and egr-2 in heart disease | |
| AU4582597A (en) | Therapeutic proteins |
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |